
Sterling Pharma Solutions Welcomes Karl Rotthier as new CEO
Sterling Pharma Solutions announced the appointment of Karl Rotthier as Chief Executive Officer (CEO), effective 21 October, 2025.

Sterling Pharma Solutions announced the appointment of Karl Rotthier as Chief Executive Officer (CEO), effective 21 October, 2025.

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.